Guangyong Zhang

Dr. Guangyong Zhang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2024 in Advanced Science
Verified
Journal Article
Open access
SDShuohui Dong
Shuohui Dong
HCHaolin Cao
Haolin Cao
YYYe Yuan
Ye Yuan
SLShuo Liang
Shuo Liang
ZFZhendong Fu
Zhendong Fu
LCLei Chen
Lei Chen
Despite considerable advancements in the treatment of colorectal cancer (CRC), the overall survival rate for patients with advanced CRC remains below 50%, primarily due to challenges posed by drug resistance and metastasis. Here, a novel “Three‐in‐One” Cu‐based metal‐organic framework nanozyme with peroxidase‐like (POD‐like) activity has been successfully developed, aiming to promote CRC cell death by dual targeting of oxidative stress and copper ion homeostasis, which could promote CRC cell death via apoptosis and cuproptosis, and facilitate hypoxia‐inducible factor 1α (HIF‐1α) degradation, leading to the reversal of chemoresistance in tumor therapy. These nanozymes, composed of copper and 2‐propylimidazole (Cu‐PrIm), feature a distorted Cu‐N4 catalytic active center that mimics natural enzyme structures consisting of copper and histidine residues, endowing them with enzyme‐like activities. The antitumor efficacy of Cu‐PrIm nanozymes is validated in various in vivo models of CRC. Especially Cu‐PrIm nanozymes exhibit excellent biocompatibility, biodegradability, and a tolerable toxicity profile in mouse models, making them a strong candidate for clinical translation. Taken together, the study introduces a novel therapeutic paradigm in CRC treatment by targeting these vulnerabilities and leveraging the potential using “Three‐in‐One” Cu‐PrIm nanozymes to address multiple pathways simultaneously.

19 April 2025 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
ZZZhenguo Zhu
Zhenguo Zhu
QCQishuai Chen
Qishuai Chen
SSSiyi Song
Siyi Song
SPShi Peng
Shi Peng
HDHuanxin Ding
Huanxin Ding
GZGuangyong Zhang
Guangyong Zhang
As an important protein post-translational modification process, ubiquitination plays an indispensable role in the regulation of gastric cancer (GC) occurrence and development. And recent studies have demonstrated that this modification is closely related to regulated cell death. This suggests that our therapeutic approach to inhibit the malignant progression of GC by regulating the intracellular death mode through ubiquitination modification becomes possible. Although ubiquitination modification has been well described in some tumorigenesis, its potential role and specific mechanisms are still unknown. In the present study, we identified RNF128, an E3 ubiquitin ligase with a RING structural domain, whose expression was significantly increased in GC. In-depth studies showed that knockdown of RNF128 significantly inhibited GC cell proliferation and increased intracellular autophagic flux and lipid peroxidation production, and we hypothesized that autophagy-dependent ferroptosis might be the main mode of death mediated by RNF128. Mechanistically, RNF128 directly binds and ubiquitinates degradation of Beclin1 through its PA structural domain and significantly inhibits the Beclin1/solute transport family 7 member 11(SLC7A11)/glutathione peroxidase 4(GPX4) axis. Taken together, our study reports for the first time that RNF128 acts as a tumor promoter to inhibit autophagy-dependent ferroptosis in GCs by targeting Beclin1. These data provide new insights into the activation of intracellular ferroptosis to inhibit malignant tumor progression and are expected to provide a new strategy for molecular therapy in clinical GC patients.

15 October 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZLZhengliang Liu
Zhengliang Liu
YGYing Gao
Ying Gao
WZWenjie Zhang
Wenjie Zhang
LLLinchuan Li
Linchuan Li
HDHuanxin Ding
Huanxin Ding
GZGuangyong Zhang
Guangyong Zhang
Previous studies have suggested a potential role for paraptosis-related genes (PRGs) in cancer pathogenesis, yet their prognostic significance and therapeutic efficacy in gastric cancer (GC) remain largely unexplored. This study aims to investigate the function of PRGs in GC and offer valuable insights for clinical assessment of patient prognosis. Single-cell RNA sequencing (scRNA-seq) and the cancer genome atlas (TCGA)-GC transcriptomic data were acquired from public databases, with PRGs derived from Literature. Differential expressed genes 1 (DEGs1) were identified through scRNA-seq differential analysis. Prognostic genes were determined via regression analysis, followed by construction of prognostic models and nomograms to validate risk scores as independent predictors. Immune infiltration analysis assessed prognostic genes’ impact on the tumor microenvironment. Cell trajectory analysis elucidated critical differentiation patterns between GC and normal groups, while cell communication analysis revealed interactions between key cellular subpopulations. In this study, 3,177 DEGs were identified from scRNA-seq. A risk model using 8 prognostic genes predicted GC patient survival outcomes effectively. These genes were also validated as independent prognostic factors in a nomogram. High-risk patients showed significantly increased immunotherapy resistance. T cells and fibroblasts were more differentiated in GC patients, while neutrophils had the highest interaction intensity in both GC and normal groups, with the CXCL8-CXCR2 interaction being most significant (p < 0.01). This study identified 8 prognostic genes (ABRACL, RANBP1, RAMP1, CCT2, AKR1A1, NPTN, ITGA8, CLU) and combined single-cell and transcriptome analysis to offer new insights into potential GC treatment strategies.

21 November 2025 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
QXQian Xu
Qian Xu
LLLinchuan Li
Linchuan Li
SSSiyi Song
Siyi Song
HDHuanxin Ding
Huanxin Ding
CLChuxuan Liu
Chuxuan Liu
GZGuangyong Zhang
Guangyong Zhang

14 February 2026 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
JZJiankang Zhu
Jiankang Zhu
YZYun Zhang
Yun Zhang
BLBingjun Li
Bingjun Li
XJXin Jin
Xin Jin
CLChuxuan Liu
Chuxuan Liu
GZGuangyong Zhang
Guangyong Zhang
High reactive oxygen species (ROS) concentration displays dual functions, potentially promoting both tumor cell death and driving tumor-associated macropha

9 September 2026 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
SDShuohui Dong
Shuohui Dong
QXQian Xu
Qian Xu
MZMingguang Zhang
Mingguang Zhang
SLShuo Liang
Shuo Liang
XZXiang Zhao
Xiang Zhao
GZGuangyong Zhang
Guangyong Zhang
Drug-tolerant persister (DTP) cells survive anticancer therapy through reversible adaptive states and can contribute to tumor regrowth. However, how colore